Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Myeloablative Conditioning
70%
Autoimmune Neutropenia
55%
Hematopoietic Stem Cell Transplantation
52%
Hematopoietic Cell Transplantation
52%
Graft-versus-host Disease (GvHD)
45%
Guinea-Bissau
41%
Early childhood
41%
Chimerism
34%
Quantitative PCR
29%
Denmark
28%
Nonmyeloablative
27%
CD8+ T Cells
27%
Pediatric Patients
27%
Rural Areas
27%
Urban Areas
27%
Genotype
26%
Total Body Irradiation
22%
Hazard Ratio
19%
Genetic Variation
19%
Leukemia
18%
Chimerism Analysis
18%
Autosomal Recessive
18%
Relapse Risk
18%
HLA-DQB1
17%
Day 14
17%
Viral
16%
Hematological Malignancies
15%
Fc Receptor
15%
High-resolution
15%
West Africa
13%
Ketogenic Diet
13%
Hematopoietic chimerism
13%
Telomere Dysfunction
13%
Activated Phosphoinositide 3-kinase δ Syndrome
13%
Non-pharmacological Methods
13%
Treatment Options
13%
Anticancer Immune Response
13%
Fcgr2b
13%
HAX1 mutation
13%
Epilepsy
13%
Congenital Neutropenia
13%
HAX-1
13%
β-Thalassemia (β-thal)
13%
IFNAR2
13%
HLA-identical
13%
Histo-blood Group
13%
Chronic Lymphocytic Leukemia
13%
Adults with Epilepsy
13%
Psychological Consequences
13%
Immunology and Microbiology
Hematopoietic Cell
98%
Cell Transplantation
96%
Conditioning
61%
Chimera
56%
Hematopoietic Stem Cell Transplantation
34%
Autosomal Recessive Inheritance
27%
Acute Graft Versus Host Disease
24%
Real-Time Polymerase Chain Reaction
24%
Neutrophil
22%
T Cell
21%
Genetic Variation
19%
Cytotoxic T-Cell
17%
Myeloid
16%
Autoantibodies
15%
Overall Survival
15%
Fc Receptor
15%
Progression Free Survival
14%
CD8 Lymphocyte Count
13%
FCGR2B
13%
Human Leukocyte Antigen
13%
Arm
13%
Blood Group Lewis System
13%
Microchimerism
13%
Minor Histocompatibility Antigen
13%
Infancy
13%
Immune Response
13%
Granulocyte Colony-Stimulating Factor
13%
Allogeneic Hematopoietic Stem Cell Transplantation
13%
Nonmyeloablative Stem Cell Transplantation
13%
Maturation
13%
Myelopoiesis
13%
Mortality Rate
13%
Neutrophil Count
13%
Polymerase Chain Reaction
13%
Blood Group
13%
Hematopoietic Stem Cell
13%
Blood Plasma
13%
Viral Disease
13%
FCGR3B
12%
Monospecific Antibody
12%
Allele
9%
Protein Polymorphism
9%
FCGR2A
9%
Severe Combined Immunodeficiency
9%
Homozygosity
8%
Real Time Polymerase Chain Reaction
8%
Inflammatory Disorder
7%
Graft-Versus-Host Disease
7%
Storage Temperature
6%
Viral Immunity
6%
Medicine and Dentistry
Cell Transplantation
68%
Hematopoietic Stem Cell
68%
Nonmyeloablative Conditioning
43%
Disease
40%
Hematopoietic Stem Cell Transplantation
36%
Autoimmune neutropenia
27%
Prevalence
20%
Whole Body Radiation
20%
Graft Versus Host Reaction
18%
Pediatrics
18%
Chimera
14%
Cytotoxic T-Cell
14%
Telomere
13%
Diet Therapy
13%
Systematic Review
13%
Ketogenic Diet
13%
Acute Lymphoblastic Leukemia
13%
Vagus Nerve Stimulation
13%
Epileptic Seizure
13%
Epilepsy Surgery
13%
Minor Histocompatibility Antigen
13%
Pediatrics Patient
13%
Orphan
13%
Neutropenia
13%
Drug Therapy
13%
Photopheresis
13%
Non Melanoma Skin Cancer
13%
Beta Thalassemia
13%
Retrospective Study
13%
Population Research
13%
Allogeneic Hematopoietic Stem Cell Transplantation
13%
B-Cell Chronic Lymphocytic Leukemia
13%
Recurrent Disease
13%
Drug Resistant Epilepsy
13%
Microchimerism
13%
Mortality Rate
13%
Late Effect
13%
Immune Response
13%
Blood Group
13%
Blood Group Lewis System
13%
Graft Rejection
13%
Genotype
13%
Allele
13%
T Cell
11%
Occupational Exposure
10%
Cohort Analysis
9%
Hematologic Malignancy
9%
Haplotype
8%
Epitope
8%
Overall Survival
8%